Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The nanoparticle protein corona is a complex coating of proteins and other biomolecules that spontaneously forms on the surface of nanoparticles when they come into contact with biological fluids such as blood, plasma, or interstitial fluid (Monopoli et al., 2012). This corona is categorized into a hard corona of tightly bound proteins and a soft corona of weakly interacting, rapidly exchanging proteins (Walkey & Chan, 2012). It effectively masks the nanoparticle's original surface chemistry, providing it with a biological identity that determines its physiological fate, including its circulation time, biodistribution, and cellular internalization pathways (Brummer et al., 2020). While the corona can lead to rapid clearance by the mononuclear phagocyte system through opsonization, it can also be exploited for targeted delivery; for instance, the adsorption of apolipoproteins can facilitate transport across the blood-brain barrier (Cejka et al., 2020). Consequently, the protein corona is a pivotal factor in the design and efficacy of nanotherapeutics, influencing both their safety profile and therapeutic outcomes.
The protein corona dictates the biological identity of nanoparticles, modulating their interaction with cell surface receptors and the immune system (Walkey & Chan, 2012).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nanoparticle protein corona (NP-PC).